BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas D, Shenoy S, Sayed N. Building Multi-Dimensional Induced Pluripotent Stem Cells-Based Model Platforms to Assess Cardiotoxicity in Cancer Therapies. Front Pharmacol 2021;12:607364. [PMID: 33679396 DOI: 10.3389/fphar.2021.607364] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Satsuka A, Hayashi S, Yanagida S, Ono A, Kanda Y. Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance. Journal of Pharmacological and Toxicological Methods 2022;118:107227. [DOI: 10.1016/j.vascn.2022.107227] [Reference Citation Analysis]
2 Zhou B, Shi X, Tang X, Zhao Q, Wang L, Yao F, Hou Y, Wang X, Feng W, Wang L, Sun X, Wang L, Hu S. Functional isolation, culture and cryopreservation of adult human primary cardiomyocytes. Signal Transduct Target Ther 2022;7:254. [PMID: 35882831 DOI: 10.1038/s41392-022-01044-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Maria Cherian R, Prajapati C, Penttinen K, Häkli M, Koivisto JT, Pekkanen-mattila M, Aalto-setälä K. Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays. Cell Biol Toxicol. [DOI: 10.1007/s10565-022-09742-0] [Reference Citation Analysis]
4 Tang X, Wang Z, Hu S, Zhou B. Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation. Pharmaceutics 2022;14:1313. [DOI: 10.3390/pharmaceutics14071313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dunham CS, Mackenzie ME, Nakano H, Kim AR, Nakano A, Stieg AZ, Gimzewski JK. Cardio PyMEA: A user-friendly, open-source Python application for cardiomyocyte microelectrode array analysis. PLoS ONE 2022;17:e0266647. [DOI: 10.1371/journal.pone.0266647] [Reference Citation Analysis]
6 Dunham CS, Mackenzie ME, Nakano H, Kim AR, Nakano A, Stieg AZ, Gimzewski JK. Cardio PyMEA: A user-friendly, open-source Python application for cardiomyocyte microelectrode array analysis.. [DOI: 10.1101/2022.03.25.485780] [Reference Citation Analysis]
7 Huang MF, Pang LK, Chen YH, Zhao R, Lee DF. Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cells 2021;10:2823. [PMID: 34831045 DOI: 10.3390/cells10112823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu C, Medina P, Thomas D, Chen IY, Sallam K, Sayed D, Sayed N. A protocol for transdifferentiation of human cardiac fibroblasts into endothelial cells via activation of innate immunity. STAR Protoc 2021;2:100556. [PMID: 34151292 DOI: 10.1016/j.xpro.2021.100556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jiang X, Cheng H, Huang J, Cui C, Zhu Y, Lin Y, Miao W, Liu H, Chen H, Ju W, Chen M. Construction of chamber-specific engineered cardiac tissues in vitro with human iPSC-derived cardiomyocytes and human foreskin fibroblasts. J Biosci Bioeng 2021;132:198-205. [PMID: 34074596 DOI: 10.1016/j.jbiosc.2021.04.012] [Reference Citation Analysis]
10 Thomas D, Cunningham NJ, Shenoy S, Wu JC. Human iPSCs in Cardiovascular Research: Current Approaches in Cardiac Differentiation, Maturation Strategies, and Scalable Production. Cardiovasc Res 2021:cvab115. [PMID: 33757124 DOI: 10.1093/cvr/cvab115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]